The usefulness of plateletcrit to predict cardiac syndrome X in patients with normal coronary angiogram

Basit Öğe Kaydı
dc.contributor.authorOylumlu, Muhammed
dc.contributor.authorOylumlu, Mustafa
dc.contributor.authorYuksel, Murat
dc.contributor.authorDogan, Adnan
dc.contributor.authorCakici, Musa
dc.contributor.authorOzgeyik, Mehmet
dc.contributor.authorYildiz, Abdulkadir
dc.date.accessioned2024-04-24T17:24:55Z
dc.date.available2024-04-24T17:24:55Z
dc.date.issued2015
dc.departmentDicle Üniversitesien_US
dc.description.abstractIntroduction: Cardiac syndrome X (CSX) is a clinical entity defined as the triad of typical angina pectoris on exercise, electro-cardiographic or metabolic findings of ischemia and normal epicardial coronary arteries. Platelets, whose amount in the blood is indicated with plateletcrit (PCT), play an important role in inflammatory and thrombotic processes and the physiopathology of cardiovascular events. Aim: To investigate the association between cardiac syndrome X and PCT and platelet count. Material and methods: A total of 113 patients with normal coronary angiogram were included in the study. Fifty patients with typical chest pain and evidence of myocardial ischemia in non-invasive tests formed the CSX patient group. The control group consisted of 63 age- and gender-matched patients with normal coronary arteries but without angina. Results: The mean PCT value of the CSX group was significantly higher than that of the control group (0.22 +/- 0.06 vs. 0.19 +/- 0.04; respectively, p = 0.03). Higher PCT was found to be associated with the presence of CSX in patients with normal coronary arteries by multivariate logistic regression analysis. Conclusions: We suggest that high PCT may predict the presence of cardiac syndrome X in patients with normal coronary arteries. The value of PCT appears additive to conventional expensive methods commonly used in CSX prediction.en_US
dc.identifier.doi10.5114/pwki.2015.54013
dc.identifier.endpage201en_US
dc.identifier.issn1734-9338
dc.identifier.issn1897-4295
dc.identifier.issue3en_US
dc.identifier.pmid26677359
dc.identifier.scopus2-s2.0-84945185227
dc.identifier.scopusqualityQ3
dc.identifier.startpage197en_US
dc.identifier.urihttps://doi.org/10.5114/pwki.2015.54013
dc.identifier.urihttps://hdl.handle.net/11468/19878
dc.identifier.volume11en_US
dc.identifier.wosWOS:000362057400007
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherTermedia Publishing House Ltden_US
dc.relation.ispartofPostepy W Kardiologii Interwencyjnej
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCardiac Syndrome Xen_US
dc.subjectPlateletcriten_US
dc.subjectPlatelet Counten_US
dc.titleThe usefulness of plateletcrit to predict cardiac syndrome X in patients with normal coronary angiogramen_US
dc.titleThe usefulness of plateletcrit to predict cardiac syndrome X in patients with normal coronary angiogram
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu